Riccardo Giampieri

3.5k total citations
122 papers, 2.2k citations indexed

About

Riccardo Giampieri is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Riccardo Giampieri has authored 122 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 81 papers in Oncology, 54 papers in Pulmonary and Respiratory Medicine and 27 papers in Cancer Research. Recurrent topics in Riccardo Giampieri's work include Colorectal Cancer Treatments and Studies (56 papers), Gastric Cancer Management and Outcomes (26 papers) and Hepatocellular Carcinoma Treatment and Prognosis (23 papers). Riccardo Giampieri is often cited by papers focused on Colorectal Cancer Treatments and Studies (56 papers), Gastric Cancer Management and Outcomes (26 papers) and Hepatocellular Carcinoma Treatment and Prognosis (23 papers). Riccardo Giampieri collaborates with scholars based in Italy, United States and Saudi Arabia. Riccardo Giampieri's co-authors include Mario Scartozzi, Stefano Cascinu, Rossana Berardi, Alessandro Bittoni, Maristella Bianconi, Luca Faloppi, Michela Del Prete, Gennaro Galizia, Elena Maccaroni and Chiara Pierantoni and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Riccardo Giampieri

119 papers receiving 2.2k citations

Peers

Countries citing papers authored by Riccardo Giampieri

Since Specialization

Citations

This map shows the geographic impact of Riccardo Giampieri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Riccardo Giampieri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Riccardo Giampieri more than expected).

Fields of papers citing papers by Riccardo Giampieri

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Riccardo Giampieri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Riccardo Giampieri. The network helps show where Riccardo Giampieri may publish in the future.

Co-authorship network of co-authors of Riccardo Giampieri

This figure shows the co-authorship network connecting the top 25 collaborators of Riccardo Giampieri. A scholar is included among the top collaborators of Riccardo Giampieri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Riccardo Giampieri. Riccardo Giampieri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Treatment of patients with BRAF-mutated metastatic colorectal cancer after progression to encorafenib and cetuximab: data from a real-world nationwide dataset 2024 ·ESMO Open ·Marco Maria Germani, (unknown), (unknown), Rossana Intini, (unknown), Maria Bensi, Alessandra Boccaccino, Alessandro Minelli, (unknown), (unknown), Alessandro Passardi, (unknown), Riccardo Giampieri, Mara Persano, Elisabetta Fenocchio, Alberto Puccini, Sara Lonardi, Filippo Pietrantonio, Lisa Salvatore, Chiara Cremolini	4
2	Lynch syndrome-associated lung cancer: pitfalls of an immunotherapy-based treatment strategy in an unusual tumor type 2021 ·SHILAP Revista de lepidopterología ·Elena Maccaroni, (unknown), Veronica Agostinelli, (unknown), Riccardo Giampieri, Paola Mazzanti, (unknown), Francesca Bianchi, (unknown), Laura Belvederesi, (unknown), Alessandra Mandolesi, Marina Scarpelli, (unknown), Francesca Morgese, Z. Ballatore, Rossana Berardi	3
3	Retrospective Cohort Study of Caveolin-1 Expression as Prognostic Factor in Unresectable Locally Advanced or Metastatic Pancreatic Cancer Patients 2021 ·Current Oncology ·Alessandro Bittoni, Riccardo Giampieri, Federica Pecci, (unknown), Alessandra Mandolesi, (unknown), Antonio Zizzi, (unknown), (unknown), Giulia Mentrasti, Luca Cantini, (unknown), Renato Bisonni, Marina Scarpelli, Rossana Berardi	1
4	35P Lung cancer diagnosis and continuum of care: How did the COVID-19 outbreak impact? Data from an Italian multicenter study 2021 ·Journal of Thoracic Oncology ·Luca Cantini, Giulia Mentrasti, Nicla La Verde, Maria Silvia Cona, Rita Chiari, Erika Martinelli, Floriana Morgillo, Linda Nicolardi, Alessio Cortellini, (unknown), (unknown), (unknown), (unknown), Federica Pecci, Paola Mazzanti, (unknown), Riccardo Giampieri, Rossana Berardi	1
5	Systemic immune-inflammation index: a prognostic tiebreaker among all in advanced pancreatic cancer 2021 ·Annals of Translational Medicine ·Alessandro Bittoni, Federica Pecci, Giulia Mentrasti, (unknown), (unknown), Andrea Lanese, (unknown), (unknown), Luca Cantini, Riccardo Giampieri, (unknown), (unknown), Federica Bini, (unknown), (unknown), (unknown), Rossana Berardi	31
6	Benefits and Limitations of a Multidisciplinary Approach in Cancer Patient Management 2020 ·SHILAP Revista de lepidopterología ·Rossana Berardi, Francesca Morgese, Silvia Rinaldi, Mariangela Torniai, Giulia Mentrasti, (unknown), Riccardo Giampieri	1
7	Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH): Optimal Management 2020 ·SHILAP Revista de lepidopterología ·Giulia Mentrasti, (unknown), Mariangela Torniai, Riccardo Giampieri, Francesca Morgese, Silvia Rinaldi, Rossana Berardi	1
8	Angiogenesis Genotyping and Clinical Outcomes in Patients with Advanced Hepatocellular Carcinoma Receiving Sorafenib: The ALICE-2 Study 2020 ·Targeted Oncology ·Luca Faloppi, Marco Puzzoni, Andrea Casadei‐Gardini, Nicola Silvestris, Gianluca Masi, Giorgia Marisi, Caterina Vivaldi, Cosmo Damiano Gadaleta, Pina Ziranu, Maristella Bianconi, Cristian Loretelli, Laura Demurtas, Eleonora Lai, Riccardo Giampieri, Gennaro Galizia, Paola Ulivi, Nicola Battelli, Alfredo Falcone, Stefano Cascinu, Mario Scartozzi	14
9	Prognostic Value of Thyroid Hormone Ratios in Patients With Advanced Metastatic Colorectal Cancer Treated With Regorafenib: The TOREADOR Study 2018 ·Clinical Colorectal Cancer ·Marta Schirripa, Giuseppe Pasqualetti, Riccardo Giampieri, Mario Scartozzi, Sara Lonardi, (unknown), Francesca Bergamo, Silvia Stragliotto, Sabina Murgioni, (unknown), Mario Domenico Rizzato, Alessandra Anna Prete, Marco Puzzoni, Valeria Pusceddu, Pina Ziranu, Fabiana Pani, Stefano Mariotti, Vittorina Zagonel, Fabio Monzani, Fotios Loupakis	11
10	Prognostic factors in advanced pancreatic cancer patients receiving second-line chemotherapy: a single institution experience 2018 ·Translational Cancer Research ·Alessandro Bittoni, (unknown), Andrea Lanese, Riccardo Giampieri, (unknown), (unknown), Luca Cantini, (unknown), (unknown), Rossana Berardi	3
11	Optimal management of resected gastric cancer 2018 ·Cancer Management and Research ·Riccardo Giampieri, Michela Del Prete, Luca Cantini, (unknown), Alessandro Bittoni, Elena Maccaroni, Rossana Berardi	14
12	Prognostic impact of CA15-3 pre-treatment levels in ovarian cancer patients 2017 ·Annals of Oncology ·Elena Maccaroni, Riccardo Giampieri, Michela Del Prete, (unknown), R. Bracci, (unknown), (unknown), Francesca Bianchi, Laura Belvederesi, (unknown), (unknown), Mirco Pistelli, Agnese Savini, (unknown), Z. Ballatore, Federica Bini, (unknown), Luca Cantini, (unknown), Rossana Berardi	1
13	Tumor infiltrating lymphocytes in gastrointestinal tumors: Controversies and future clinical implications 2016 ·Critical Reviews in Oncology/Hematology ·Cinzia Solinas, (unknown), Laura Demurtas, Marco Puzzoni, (unknown), Gilberto Morgan, Riccardo Giampieri, Mario Scartozzi	36
14	The Immune Revolution in Gastrointestinal Tumours: Leading the Way or Just Following? 2016 ·Targeted Oncology ·Marco Puzzoni, Nicola Silvestris, Francesco Leone, Riccardo Giampieri, Luca Faloppi, Laura Demurtas, Emanuela Dell’Aquila, Donatella Marino, Oronzo Brunetti, Silvio Ken Garattini, Elena Ongaro, Giorgio Astara, L. Orgiano, Giuseppe Aprile, Daniele Santini, Mario Scartozzi	15
15	Trattamento del carcinoma del pancreas. Attualità e prospettive 2015 ·Recenti Progressi in Medicina ·Alessandro Bittoni, Kalliopi Andrikou, Andrea Lanese, Matteo Santoni, (unknown), Luca Faloppi, (unknown), Riccardo Giampieri, Stefano Cascinu	2
16	The distinctive molecular, pathological and clinical characteristics ofBRAF-mutant colorectal tumors 2015 ·Expert Review of Molecular Diagnostics ·Mario Scartozzi, Riccardo Giampieri, Giuseppe Aprile, Donatella Iacono, Daniele Santini, Emanuela Dell’Aquila, Nicola Silvestris, Antonio Gnoni, Marta Bonotto, Marco Puzzoni, Laura Demurtas, Stefano Cascinu	10
17	The challenge of targeted therapies for gastric cancer patients: the beginning of a long journey 2014 ·Expert Opinion on Investigational Drugs ·Giuseppe Aprile, Riccardo Giampieri, Marta Bonotto, Alessandro Bittoni, Elena Ongaro, Giovanni Gerardo Cardellino, Francesco Graziano, Francesco Giuliani, (unknown), Stefano Cascinu, Mario Scartozzi	25
18	Clinical Evidence for Three Distinct Gastric Cancer Subtypes: Time for a New Approach 2013 ·PLoS ONE ·Alessandro Bittoni, Mario Scartozzi, Riccardo Giampieri, Luca Faloppi, Maristella Bianconi, Alessandra Mandolesi, Michela Del Prete, Mirco Pistelli, Luca Cecchini, Italo Bearzi, Stefano Cascinu	56
19	Analysis of HER-3, insulin growth factor-1, nuclear factor-kB and epidermal growth factor receptor gene copy number in the prediction of clinical outcome for K-RAS wild-type colorectal cancer patients receiving irinotecan–cetuximab 2011 ·Annals of Oncology ·Mario Scartozzi, Riccardo Giampieri, Elena Maccaroni, Alessandra Mandolesi, Lucio Giustini, (unknown), Alberto Zaniboni, Tommasina Biscotti, (unknown), Gennaro Galizia, Fotios Loupakis, Alfredo Falcone, Italo Bearzi, Stefano Cascinu	35
20	Arterial hypertension correlates with clinical outcome in colorectal cancer patients treated with first-line bevacizumab 2008 ·Annals of Oncology ·Mario Scartozzi, Gennaro Galizia, Silvia Chiorrini, Riccardo Giampieri, Rossana Berardi, Chiara Pierantoni, Stefano Cascinu	261

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact